Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions Trigger elimination or substrate modification: Early or delayed cure? by Kottkamp, Hans et al.
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trial Fibrillation Episode Number and Duration
fter Circular Plus Linear Left Atrial Lesions
rigger Elimination or Substrate Modification: Early or Delayed Cure?
ans Kottkamp, MD, Hildegard Tanner, MD, Richard Kobza, MD, Petra Schirdewahn, MD,
nja Dorszewski, MD, Jin-Hong Gerds-Li, MD, Corrado Carbucicchio, MD,
hristopher Piorkowski, MD, Gerhard Hindricks, MD
eipzig, Germany
OBJECTIVES We sought to analyze the time course of atrial fibrillation (AF) episodes before and after
circular plus linear left atrial ablation and the percentage of patients with complete freedom
from AF after ablation by using serial seven-day electrocardiograms (ECGs).
BACKGROUND The curative treatment of AF targets the pathophysiological corner stones of AF (i.e., the
initiating triggers and/or the perpetuation of AF). The pathophysiological complexity of both
may not result in an “all-or-nothing” response but may modify number and duration of AF
episodes.
METHODS In patients with highly symptomatic AF, circular plus linear ablation lesions were placed
around the left and right pulmonary veins, between the two circles, and from the left circle
to the mitral annulus using the electroanatomic mapping system. Repetitive continuous 7-day
ECGs administered before and after catheter ablation were used for rhythm follow-up.
RESULTS In 100 patients with paroxysmal (n  80) and persistent (n  20) AF, relative duration of
time spent in AF significantly decreased over time (35  37% before ablation, 26  41%
directly after ablation, and 10  22% after 12 months). Freedom from AF stepwise increased
in patients with paroxysmal AF and after 12 months measured at 88% or 74% depending on
whether 24-h ECG or 7-day ECG was used. Complete pulmonary vein isolation was
demonstrated in 20% of the circular lesions.
CONCLUSIONS The results obtained in patients with AF treated with circular plus linear left atrial lesions
strongly indicate that substrate modification is the main underlying pathophysiologic
mechanism and that it results in a delayed cure instead of an immediate cure. (J Am Coll
Cardiol 2004;44:869–77) © 2004 by the American College of Cardiology Foundationi
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btrial fibrillation (AF) is an arrhythmic manifestation of a
omplex, chronic, and progressive disease of the atria with
lectrical, contractile, and structural remodeling that often
radually worsens over time (1,2). The curative treatment of
F involves targeting the pathophysiological cornerstones
f AF (i.e., the initiating triggers and/or the perpetuation of
he arrhythmia) (3–8). The pathophysiological complexity
f both the initiation as well as the perpetuation is likely to
esult in a clinical outcome after ablation that differs from
esults that have been obtained in arrhythmias like atrial
utter or accessory atrioventricular pathways, which have
ell-defined reentrant circuits. Therefore, ablation strate-
ies for the treatment of AF may not necessarily result in a
all-or-nothing” response (i.e., AF is unchanged after abla-
ion or completely prevented), but ablation may rather
uantitatively modify the number and/or duration of indi-
idual AF episodes and, in addition, may result in a gradual
From the University of Leipzig, Heart Center, Cardiology, Department of
lectrophysiology, Leipzig, Germany. Drs. Kottkamp and Hindricks have received
unding from Biosense Webster Inc., which supported this study in part by an
nrestricted educational grant. Dr. Tanner was supported by a grant from the Swiss
ational Research Foundation.
Manuscript received January 29, 2004; revised manuscript received April 22, 2004,lccepted April 27, 2004.mprovement over time as the result of atrial “reverse
emodeling.”
In the present study, radiofrequency energy-induced cir-
ular plus linear lesions were percutaneously placed in the
eft atrium around the left and right pulmonary veins (PVs),
etween the encircling lines, and from the left circle to the
itral annulus. This approach was chosen to principally
arget both the initiation as well as the perpetuation of AF.
sing repetitive continuous 7-day electrocardiogram
ECG) recordings with an overall analysis of 54,000 h of
CG, we sought to analyze the time course of total time
pent in AF before and after ablation, the percentage of
atients with complete freedom from AF after ablation by
omparing classic 24-h ECG versus 7-day ECG, as well as
he time course of the number and duration of recurrent
ndividual AF episodes after ablation.
ETHODS
atient population. In this prospective study, 100 consec-
tive patients with paroxysmal (n  80) or persistent (n 
0) AF were included (Table 1). In all patients, AF was
ocumented on ECG/Holter-ECG at least three times
efore ablation. Persistent AF was defined as AF lasting at
east for 7 days according to the Consensus Paper (9). As an
i
d
(
t
a
i
t
R
c
e
r
w
i
v
f
h
e
t
p
i
e
(
t
M
c
u
u
c
s
n
t
A
t
i
a
f
p
t
p
s
s
T
A
M
P
P
A
A
A
C
V
D
L
L
L
N
P
P
P
A
F
n
e
l
w
c
t
i
L
P
u
870 Kottkamp et al. JACC Vol. 44, No. 4, 2004
Substrate Modification in AF August 18, 2004:869–77nclusion criterion, all patients were highly symptomatic
espite multiple antiarrhythmic drug treatment regimens
Table 1). Left heart catheterization and transthoracic/
ransesophageal echocardiography were performed before
blation. All patients gave written informed consent on the
nvestigational nature of the procedure that was approved by
he institutional review committee.
ationale for the lesion line concept. A linear lesion line
oncept confined to the left atrium targeting specifically the
limination of anatomically defined left atrial “anchor”
eentrant circuits eliminated AF in 90% of the patients
ith paroxysmal and persistent AF who were treated with
ntraoperative radiofrequency ablation using minimally in-
asive surgical techniques (7). On the other hand, circum-
erential catheter ablation around each PV at the atrial level
as been demonstrated by Pappone et al. (4) to be highly
ffective in patients with paroxysmal and persistent AF. In
he present study, radiofrequency energy-induced circular
lus linear lesions were combined and percutaneously placed
n the left atrium around the left and right PVs, between the
ncircling lines, and from the left circle to the mitral annulus
Fig. 1). This approach was chosen to principally target both
he initiation as well as the perpetuation of AF.
apping and ablation procedure. Standard multielectrode
atheters were placed in the coronary sinus and right ventric-
lar apex. After transseptal catheterization, systemic anticoag-
lation with intravenous heparin was achieved (target activated
lotting time of 200 to 250 s). The electromagnetic mapping
Abbreviations and Acronyms
AF  atrial fibrillation
ANOVA  analysis of variance
ECG  electrocardiogram
IRAAF  Intraoperative Radiofrequency Ablation of
Atrial Fibrillation study
PV  pulmonary vein
able 1. Clinical Characteristics of the Study Patients (n  100)
ge, yrs 53  10
ale, n (%) 67 (67)
aroxysmal AF, n (%) 80 (80)
ersistent AF, n (%) 20 (20)
F history, yrs 7.3  7.0
ntiarrhythmic drugs, n 2.2  1.2
rterial hypertension, n (%) 45 (45)
oronary artery disease, n (%) 14 (14)
alvular heart disease or CM, n (%) 11 (11)
iabetes mellitus, n (%) 6 (6)
one AF, n (%) 42 (42)
eft atrial diameter, mm 40  8
V ejection fraction, % 61  7
o previous ablation attempt, n (%) 72 (72)
revious AF ablation or operation,
n (%)
14 (14)
revious atrial flutter ablation, n (%) 10 (10)
revious other arrhythmia ablation,
n (%)
4 (4)aF  atrial fibrillation; CM  cardiomyopathy; LV  left ventricular.ystem (Carto, Biosense Webster Inc., Diamond Bar, Califor-
ia) was used for reconstruction of the left atrium and naviga-
ion of the ablation catheter (Navistar, Biosense Webster Inc.).
ll PVs were visited with the mapping/ablation catheter and
agged. The vein-atrium transition was determined combining
nformation from the fluoroscopic cardiac silhouette, imped-
nce changes, and PV-atrium electrogram characteristics (i.e.,
usion of the atrial electrogram component and the PV
otential component). In addition, the mitral annulus was
agged. Ablation was performed during sinus rhythm. In
atients with sustained AF at the beginning of the procedure,
inus rhythm was achieved with electrical cardioversion and
tabilized, if necessary, with intravenous amiodarone or
igure 1. (A) Schematic drawing of the left atrium, including the pulmo-
ary veins (PV), the mitral annulus (MA), and the radiofrequency
nergy-induced lesion lines. A circumferential lesion was placed around the
eft and right PVs 5 mm from the orifices. In addition, two linear lesions
ere placed, one connecting the circular lesions and one connecting the left
ircular lesion with the MA (so-called left atrial isthmus). (B) Posteroan-
erior view of an electroanatomic reconstruction of the left atrium,
ncluding the PV. Dark red dots represent ablation lines as described above.
AA  left atrial appendage; LLPV  left lower PV; LUPV  left upper
V; RLPV  right lower PV; RMPV  right middle PV; RUPV  right
pper PV.jmalin.
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August 18, 2004:869–77 Substrate Modification in AFRadiofrequency alternating current was delivered in a
nipolar mode between the 8-mm tip electrode of the
blation catheter and an external backplate electrode.
emperature-guided energy applications were performed
preselected catheter tip temperature of 60°C, maximum
ower of 60 W). The circumferential lines were placed at a
istance of 5 mm from the PV-atrium transition zone.
ased on catheter stability, reduction in electrogram ampli-
ude/occurrence of split potentials, and achievement of the
reselected catheter tip temperature, the ablation catheter
as stepwise dragged after 20 to 30 s, and the individual
blation sites were tagged on the map. No cutoff point of
lectrogram amplitude reduction was preselected. The end
oint of the procedure was the completion of the proposed
ircular and linear lesions, whereas neither definite isolation
f the PV nor complete left atrial isthmus block was a
equired prerequisite of the procedure. However, the inves-
igators clearly tried to place the lines as continuously and
ransmurally as possible. After placement of the circular
esions, pacing maneuvers were performed inside the circles
o check for complete isolation of the PVs indicated by
onduction from the PVs across the circles to the left
trium. After completion of ablation, selective angiography
f all PVs was performed.
re- and post-ablation monitoring and management. All
atients underwent continuous 7-day ECG recordings
DelmarReynolds Medical, Irvine, California) before abla-
ion, within 1 h after ablation, and during outpatient clinic
isits 3, 6, and 12 months after ablation (see the following
ext).
From a maximum of 168 h per 7-day ECG, 148  32 h
ould be analyzed (88% of maximum recording time) and
ere evaluated. With respect to complete freedom from AF,
he 7-day ECG results were compared with the first
espective 24-h period. Individual AF episodes documented
n the 7-day ECG recordings were separated in three
roups: 30 s to 2 h, 2 h to 24 h, and 24 h.
In all patients, antiarrhythmic drug treatment was advised
sing amiodarone or the class Ic drug flecainide for the first
hree months after ablation. Oral anticoagulation was re-
uired in all patients four weeks before ablation and was
ontinued for at least three months. Especially in patients
ith persistent AF and in patients with paroxysmal AF and
nderlying structural heart disease, further continuation of
ral anticoagulation was advised.
tatistics. Results are expressed as mean values  1 SD, or
umbers and percentages, as appropriate. Continuous vari-
bles as number of AF episodes and duration per AF
pisode were compared by a one-way analysis of variance
ANOVA), post-hoc analysis with Bonferroni correction
or multiple comparisons for parametric data, and Mann-
hitney U test if normal distribution was not given.
ategorical variables as freedom from AF in 24-h ECG and
-day ECG were compared using the Fisher exact test.
uration of AF before and after ablation and after 3, 6, and2 months was compared using the general linear model for fepeated measures. A p value of 0.05 was considered
tatistically significant.
ESULTS
rocedure data, second procedures, and complications.
he total procedure time as measured from the first femoral
uncture to removal of all sheaths was 139 31 min (Table
). Complete pulmonary vein isolation was achieved in
20% of the circular lesions and did not predict freedom
rom AF over time (Table 2). In seven patients (7%) with
dditional documented typical atrial flutter, the right atrial
sthmus was successfully ablated during the same ablation
rocedure. In 22 patients (22%) with documented symp-
omatic recurrences of AF, the ablation procedure was
epeated after 7  3 months. One patient had a third
rocedure. Circular plus linear ablation lines were repeated
s in the initial procedure, with special attention to areas
ith present atrial electrograms on the original lines to close
aps. In five additional patients (5%), stable gap-related left
trial flutter occurred. The gap was successfully ablated in
wo patients, and circular plus linear ablation lines were
epeated in the remaining three patients. In eight patients
8%) with documented typical atrial flutter, right atrial
sthmus ablation was performed during follow-up. No PV
tenosis and no other procedure-related complications were
bserved.
hythm outcome. Before ablation, the overall study pop-
lation experienced AF for 35 37% of the complete 7-day
CG recording time, the patients with paroxysmal AF for
7  18%, and the patients with persistent AF for 93 
2% (Figs. 2 and 3). The relative duration of AF during
even-day ECG monitoring significantly decreased stepwise
fter ablation in patients with paroxysmal and persistent AF
Figs. 2 and 3) (repeated measures).
In patients with paroxysmal AF, the freedom from AF
tepwise increased, over time although the percentage of
atients on antiarrhythmic drugs decreased over time sub-
tantially, from 86% (70% flecainide, 16% amiodarone)
irectly after ablation to 42% after 12 months (29% flecain-
de, 13% amiodarone) (Fig. 4). In patients with paroxysmal
F, significantly more AF recurrences were detected using
-day ECG recording compared with classic 24-h ECG
irectly after ablation as well as 3 and 6 months after
blation (Fig. 4) (Fisher exact test). In contrast, the freedom
able 2. Procedure Data (n  123 in 100 patients)
ean procedure time, min 139  31
ean fluoroscopy time, min 25  10
adiofrequency energy application time, min 35  8
adiofrequency energy, J 119.637  311.437
rradiation dose, cGy/cm2 7,452  6,996
dditional right isthmus ablation, n (%) 7 (7)
omplete pulmonary vein isolation, n (%)
Left (all) 9/60 (15)
Right (all) 11/61 (18)
Both (all left and right pulmonary veins) 3/57 (5)rom AF after 12 months did not differ significantly and
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Substrate Modification in AF August 18, 2004:869–77easured 88% when 24-h ECG was used compared with
4% when 7-day ECG was used (Fisher exact test).
The time course of number of AF episodes in patients
ith recurrences after ablation did not show a significant
rend after ablation over time in patients with paroxysmal
F and significantly increased in patients with persistent
F (Fig. 5) (ANOVA). In contrast, the duration of indi-
idual AF episodes in patients with recurrences after abla-
ion decreased significantly after ablation in patients with
ersistent AF (Fig. 6) (ANOVA, Bonferroni test).
The relative distribution of the lengths of individual AF
pisodes in patients with recurrences after ablation changed
ubstantially: The relative occurrence of short episodes (0.5
in to 2 h) increased to 90% whereas the relative occurrence
f middle (2 h to 24 h) and long episodes (24 h)
ecreased (Fig. 7). Overall, only 1 of 33 patients (3%) with
aroxysmal AF who completed the 12-month follow-up
xperienced AF episodes lasting longer than 24 h compared
igure 2. Example of 7-day electrocardiogram recordings in a patient who
trial fibrillation (AF) before ablation as well as 3 and 6 months after ablat
requency profile by the abrupt occurrence of tachyarrhythmia. HR  heaith 13 of 61 patients (21%) with paroxysmal AF before Ablation (p  0.017; chi-square test), although antiarrhyth-
ic drug use declined substantially over time.
ntiarrhythmic drug use after ablation. Overall, 90% of
ll patients received previously failed antiarrhythmic drug
reatment directly after ablation: 68% flecainide and 22%
miodarone. After 12 months, antiarrhythmic drugs were
ignificantly reduced to 40% of the patients: 27% were on
ecainide and 13% on amiodarone. Standard doses were
sed: flecainide 100 mg twice a day and amiodarone 200 mg
nce a day after a loading dose of 12 g. Antiarrhythmic
rugs were stopped after three months if no other than early
F recurrences—within the first week after ablation—
ccurred. In the other patients, antiarrhythmic drugs were
topped if they had no further AF recurrences.
nticoagulation after ablation. In the group of patients
ith paroxysmal AF, oral anticoagulation was administered
n 96% after 3 months, 84% after 6 months, and 74% after
2 months ablation. In the group of patients with persistent
erwent placement of circular plus linear left atrial lesions for treatment of
n this case, the paroxysms of AF were easily recognized on the seven-day
e.und
ion. I
rt ratF, anticoagulation was continued in 66% after 6 and 12
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August 18, 2004:869–77 Substrate Modification in AFonths. No thromboembolic complications or major bleed-
ngs were observed in the entire study population during a
ean follow-up of 12  5 months.
ISCUSSION
ain findings. In the present study, results of catheter
blation of AF are described for the first time with time courses
f relative time spent in AF and time courses of freedom from
F plus quantitative analysis of individual AF episode number
nd duration during follow-up using serial continuous 7-day
CG recordings. Freedom from AF increased stepwise over
igure 3. Relative duration of atrial fibrillation (AF) in % of total recording
uring 7-day electrocardiogram (ECG) recording before ablation, directly
fter ablation, and 3, 6, and 12 months after placement of circular plus
inear left atrial lesions.ime in patients with paroxysmal AF and, 12 months after lblation, complete freedom from AF was measured in 88% or
4% of the patients, depending on whether classic 24-h ECG
r 7-day ECG results were analyzed. Complete pulmonary
ein isolation was demonstrated in 20% of patients. The
esults obtained in patients with AF treated with circular plus
igure 4. Freedom from atrial fibrillation (AF) with comparison of classic
4-h Holter-electrocardiogram (ECG) versus 7-day ECG and percentage
f patients on antiarrhythmic drugs (AAD) after placement of circular plus
inear left atrial lesions. Open bars  24-h ECG; closed bars  7-day
CG.inear left atrial lesions using the electromagnetic mapping
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Substrate Modification in AF August 18, 2004:869–77ystem strongly indicate that substrate modification is the main
nderlying pathophysiologic mechanism and that it results in a
elayed cure instead of an immediate cure.
atient description and AF characterization. Atrial fi-
rillation is classified as paroxysmal, persistent, or perma-
ent (9). Pathophysiologically, however, AF is an arrhyth-
ic manifestation of a complex, chronic, and progressive
isease of the atria with electrical, contractile, and structural
emodeling that often gradually worsens over time (1,2).
hus, a more gradual transition of arrhythmia length often
ccurs clinically, with short bursts of atrial tachycardia at the
eginning followed by first short episodes of paroxysmal
F, then longer and even longer episodes of paroxysmal AF
ith time, until finally many patients end with persistent
igure 5. Time course of number of atrial fibrillation (AF) episodes in
atients with recurrent AF episodes after placement of circular plus linear
eft atrial lesions. ECG  electrocardiogram.F. The different type of paroxysmal AF with respect to wrrhythmia length may have an impact on ablation efficacy
epending on the ablation strategy used. In the present
tudy, pre-ablation seven-day ECG monitoring was helpful
n characterizing our patients with AF in a more quantita-
ive way, i.e., our patients with paroxysmal AF actually were
n AF for 17% of the time before ablation. Such a quanti-
ative description of the pre-ablation arrhythmia character-
stics may not only be helpful for the analysis of the
ndividual study results but may also allow a better analysis
f divergent results in comparison with other studies.
Interestingly, patients with persistent AF in this study were
n the state of arrhythmia for only 93% of the time during
re-ablation, although persistent AF was defined as AF lasting
t least seven days, according to the Consensus Paper (9),
igure 6. Time course of duration of individual atrial fibrillation (AF)
pisodes in patients with recurrent AF episodes after placement of circular
lus linear left atrial lesions. ECG  electrocardiogram.hich described seven days as the lower limit for persistent AF.
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August 18, 2004:869–77 Substrate Modification in AFn two patients with confirmed persistent AF, one episode
ach of sinus rhythm was present during the pre-ablation 7-day
CG. However, repetitive Holter-ECG before study entry
ad shown persistent AF. Thus, even seemingly long-standing
ersistent AF may occasionally terminate for limited time
eriods over time.
nterventional treatment strategies for AF. Interven-
ional strategies for a curative treatment of AF target the
athophysiological corner stones of AF (i.e., the initiating
igure 7. Time course of the relative distribution of length of individual
trial fibrillation (AF) episodes in patients with recurrent AF episodes after
lacement of circular plus linear left atrial lesions. Closed bars  24 h;
atched bars  2 to 24 h; open bars  30 s to 2 h. ECG 
lectrocardiogram.riggers and/or the perpetuation of the arrhythmia) (3–8). rn a milestone article, in 1998 Haïssaguerre et al. (3)
escribed the spontaneous initiation of AF by ectopic beats
riginating in the PVs. The initiation of the foci during the
lectrophysiologic study, however, is not reproducible and,
herefore, the local distribution of the foci can only be
stimated. Elimination of the initiating triggers for curative
reatment of AF may be difficult for several reasons. Al-
hough many of the foci are located within the PVs, other
ocations within either atrium are not uncommon and
ecently have been described to occur in up to 30% of
atients with paroxysmal AF (10,11). Furthermore, studies
sing biatrial basket electrode mapping demonstrated that
he earliest activation sites of atrial ectopic beats emerging
fter successful electrical cardioversion of persistent AF were
cattered rather than concentrated over both atria (12). In
ddition, application of the technique of mapping of specific
reakthroughs from the left atrium to the PVs and the use
f partial perimetric ablation allowing ostial PV disconnec-
ion (13) will miss foci that are related to the PVs but are
ocated proximal to the disconnection sites in the funnel
haped transition zone. So far, ablation results using the
echnique of PV disconnection in persistent AF have been
isappointing (8). Furthermore, partial perimetric ostial PV
blation always carries a risk of PV stenosis.
The Maze operation as introduced and further developed
y Cox et al. (14) often is referred to as a therapy of
ubstrate modification. However, a detailed look at the
aze procedure indicates that this highly effective proce-
ure is a hybrid approach from a pathophysiologic point of
iew: First, a substantial mass reduction is achieved with left
nd right atrial appendage amputation; second, a biatrial
ubstrate modification is accomplished with multiple left
nd right atrial incisions; and third, a relevant trigger
limination is achieved by the excision of the PV area.
herefore, the relative contribution of biatrial mass reduc-
ion, biatrial substrate modification, and PV isolation can-
ot be determined.
In contrast to the Maze procedure, a specific left atrial
inear lesion line concept for the treatment of AF targeting
t the perpetuation of AF (i.e., modification of the sub-
trate) was tested using intraoperative ablation with minimal
nvasive surgical techniques (the Intraoperative Radiofre-
uency Ablation of Atrial Fibrillation [IRAAF] study) (7).
n that study, a linear lesion line concept confined to the left
trium targeting specifically at elimination of anatomically
efined left atrial “anchor” reentrant circuits eliminated
trial fibrillation in 90% of the patients without isolation
f the PVs. The potentiality of left atrial substrate modifi-
ation (without trigger elimination and without mass reduc-
ion) as a curative treatment strategy for patients with
aroxysmal and persistent AF was highlighted in that
ntraoperative ablation study.
In 2000, Pappone et al. (4,15) introduced an anatomic
pproach using circumferential ablation of the PV ostia
uided by the electromagnetic mapping system and later
eported on the outcome in a larger patient population.
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Substrate Modification in AF August 18, 2004:869–77ircular lesions were deployed around each PV ostium at
he atrial level and isolation was defined by the achievement
f low bipolar potentials (0.1 mV) inside the circular
esions and local activation time delays of 30 ms between
ontiguous points across the line (15). Using these criteria,
solation was achieved in 75% of the patients. Interestingly,
appone et al. (15) clearly pointed out that no significant
elationship between lesion completeness and clinical out-
ome was observed and discussed that PV foci isolation
ight not have been the sole mechanism responsible for the
ure of AF. Instead, the therapeutic efficacy was discussed as
eing related in part to an alteration of the substrate,
hanges in autonomic innervation, or atrial debulking
4,15). Furthermore and in contrast to the classic PV
isconnection (8), high success rates could be achieved in
oth subgroups (i.e., in patients with paroxysmal as well as
ersistent AF) (15). In comparison to the data reported by
appone et al., the patients in our series needed more
ntiarrhythmic drugs and second procedures, which might
e related to the learning curve of our group.
In the present study, circular and linear left atrial lesions
ere combined and placed with guidance of the electromag-
etic mapping system, thereby combining elements of the
ntraoperative IRAAF study (7) and the Pappone et al. (4)
pproach. Instead of encircling each PV, one big circle was
laced around the PVs of each side, and linear lesions
onnected the two circles and also connected the left circle
o the mitral annulus. Thereby, our approach theoretically
argeted both the initiation as well as the perpetuation of
F. From a practical point of view, one big circle around the
eins of each side protects from ablation in the transition
one between the upper and lower PVs, which often are
eparated only by a small fold instead of a linear atrial wall
ntersection. Furthermore, the addition of the linear lesions
ay have contributed to the very low incidence of stable left
trial flutter after ablation.
nalysis of rhythm outcome after interventional therapy
f AF. The analysis of the rhythm outcome after intraoper-
tive ablation of AF already has indicated that early relapses of
F after ablation for substrate modification did not predict
ong-term treatment failure (7). In the IRAAF study, two-
hirds of patients with persistent and one third of patients with
aroxysmal AF were treated transiently with antiarrhythmic
rugs because of early recurrences; however, stable sinus
hythm was achieved during follow-up in 90% of both patient
ubgroups (7). To analyze the short- and long-term rhythm
esponse after catheter ablation of AF, we used repetitive 7-day
CG recordings in the present study. Our results clearly
ndicate that the arrhythmia response after catheter ablation of
F using the current technique is far from being “all or
othing.” In many patients, early AF recurrences were ob-
erved but stepwise passed away over time, indicating toward a
everse remodeling of the atria, although the percentage of
atients on antiarrhythmic drugs decreased over time substan-
ially from 90% directly after ablation to 40% after 12 months.
he significant stepwise reduction of the relative time spent inF after ablation, the unchanged or even increased number of
F episodes in patients with recurrences, as well as the
ignificant reduction of the duration of the individual AF
pisodes in patients with persistent AF all argue in favor of a
ubstrate modification instead of a trigger elimination. Inter-
stingly, the relative time spent in AF in patients with
aroxysmal AF measured 17% before ablation and even tran-
iently increased directly after ablation to 23%, thereby also
ndicating against a substantial trigger elimination. In addition,
complete isolation of the PVs as indicated by pacing
aneuvers was achieved in20% of the circular lesions in the
resent study and did not predict freedom from AF over time.
owever, the statistical power of that nonsignificant correla-
ion is limited by the small number of patients with completely
solated PVs. Moreover, the clinical success might have been
ven significantly higher when more continuous and transmu-
al lesion lines would have been accomplished resulting in
omplete PV isolation plus gap-free linear lesions.
The comparison of the “classic” 24-h ECG with the
-day ECG indicated that the rhythm outcome is overes-
imated directly after ablation and during the first 12
onths after ablation when 24-h ECGs are used.
Interestingly, only 1 of 33 patients (3%) with paroxysmal
F who completed the 12-month follow-up experienced
F episodes lasting longer than 24 h compared with 13 of
1 patients (21%) with paroxysmal AF before ablation (p 
.017). On the one hand, this finding also argues in favor of
ubstrate modification and, on the other hand, these results
ay have implications on the necessity of oral anticoagula-
ion after ablation of AF. However, results with larger
atient cohorts and longer follow-up are necessary to answer
his question.
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